COVID-19 vaccine
Oxford University testing vaccine in children
The University of Oxford plans to test its COVID-19 vaccine in children for the first time, becoming the latest vaccine developer to assess whether its coronavirus shot is effective in young people.
Malaysian PM is first recipient of COVID-19 vaccine
Malaysian Prime Minister Tan Sri Muhyiddin Yassin will be the first person to receive the COVID-19 vaccine when the national vaccination programme is implemented in the country later this month.
Covid-19 vaccination: No more ‘on-spot’ registration
The government has scrapped the ‘on-spot’ registration for coronavirus doses to avoid crowd in centres and properly run the vaccination campaign, Health Minister Zahid Maleque said Thursday.
Covid-19 in Bangladesh: Caseload now 539,571
Bangladesh’s daily coronavirus infection rate fell to 2.65 percent on Thursday as the country ramps up vaccination drive and awareness campaigns.
Motivate rural people to get vaccinated: PM Hasina
Prime Minister Sheikh Hasina on Thursday asked the members of Bangladesh Ansar and VDP to motivate rural people to receive the Covid-19 vaccine to eliminate the pandemic.
Global Covid cases surpass 107 million
Believe it or not, the total tally of global Covid-19 cases has now surpassed 107 million.
Covid-19 vaccine: 130 countries yet to administer a single dose
Almost 130 countries, with 2.5 billion people, are yet to administer a single dose of Covid-19 vaccine.
64% Bangladeshi say yes to Corona vaccine
Over 64% of people in Bangladesh say they would take the COVID vaccine, according to a survey developed in partnership with Facebook.
Rockstar James gets COVID-19 jab
Popular musician, composer and playback singer Faruq Mahfuz Anam, popularly known as James, received a COVID-19 vaccine shot on Wednesday at Bangabandhu Sheikh Mujib Medical University (BSMMU).
S. Korea approves AstraZeneca COVID-19 vaccine for all adults
South Korea's drug safety agency on Wednesday approved the vaccine for the novel coronavirus by AstraZeneca for all adults, including those aged 65 and older, amid efficacy controversies, Yonhap News Agency reported.